CFA
TMO icon

Cahill Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Cahill Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-44
Closed -$26K – 721
2021
Q3 		$26K Buy
+44
New +$24.1K 0.01% 418

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cahill Financial Advisors's TMO Position: Q4 2021 in Review

Cahill Financial Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2021, closing a stake of 44 shares — an estimated $26K sold.

Cahill Financial Advisors first reported a position in TMO in Q3 2021 and held it in 1 quarter. The position peaked at $26K in Q3 2021. 2,343 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

  • Cahill Financial Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2021 after selling out during the quarter.
  • Cahill Financial Advisors sold 44 Thermo Fisher Scientific shares in Q4 2021, an estimated $26K.
  • Cahill Financial Advisors first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 1 quarter.
  • Cahill Financial Advisors's Thermo Fisher Scientific position peaked at $26K in Q3 2021.
  • 2,343 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Cahill Financial Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.